Search Technologies

Showing 1-10 of 10 results found

Brain endothelial reporter cells

The National Cancer Institute seeks parties interested in co-development of safe and effective TEM5 agonists and/or antagonists that modulate WNT signaling.

Research Tools

GATA-3 Reporter Plasmids for Revealing Underlying Mechanisms in Breast Cancer

Researchers at the National Cancer Institute, Laboratory of Cancer Biology and Genetics believe that a better understanding of GATA-3 function and dysregulated during the onset and progression of breast cancer will lead to new strategies in diagnosing and treating the disease.

Research Tools

Human Antibody for Deploying CH2-Based Therapeutics

A human antibody that could be used safely in vitro and in vivo for the detection of CH2 (Fc and IgG as well is available of out-licensing from the National Cancer Institute.

Research Tools

Human Cell Line for Studies on Signaling and Endocrine Cancer

The National Institute of Child and Human Development seeks interested parties to further co-developa cell line with mutations in PRKAR1A, associated with tumor formation, for use a diagnostic or research tool.

Research Tools

Improved Antibodies Against ERBB4/HER4

The Eunice Kennedy Shriver National Institute of Child Health and Human Development, Section on Molecular Neurobiology seeks parties interested in licensing or collaborative research to further evaluate or commercialize specific rabbit monoclonal antibodies generated against the ErbB4 receptor (also known as HER4) that have been validated for specificity using tissue sections and extracts from ErbB4 knockout mice.

Research Tools

Improved Production of Prenylated Protein in Insect Cells

The National Cancer Institute seeks parties interested licensing and/or collaborative research to co-develop research materials for improved production of prenylated proteins.

Research Tools

Novel Fusion Proteins for HIV Vaccine

The National Cancer Institute’s Cancer and Inflammation Program seeks parties to license gp120 and CD4-induced antibody fusion proteins for use in an HIV vaccine.

Research Tools

Novel Methods for Generating Retinal Pigment Epithelium Cells from Induced Pluripotent Stem Cells

The National Eye Institute’s Ophthalmic Genetics and Visual Function Branch seeks partners to co-develop the protocol for iPSC to RPE differentiation and its use in clinical, screening and translational settings.

Research Tools

Parental A2780 Ovarian Cancer Cell Line and Derivative Cisplatin-resistant and Adriamycin-resistant A2780 Cell Lines

The National Cancer Institute (NCI) seeks non-exclusive licensees for an ovarian cancer cell line, A2780, and its cisplatin- and/or adriamycin-resistant derivatives, A2780CIS and A2780ADR. These cell lines are excellent research tools to study ovarian cancer with a focus on drug resistance.

Research Tools

Removal of Selected Proteins Using Light Energy: Photoimmunotherapy

The National Cancer Institute is seeking parties interested in collaborative research to co-develop or license the in vitro and in vivo removal of targets using light energy.

Diagnostics
Research Tools
Therapeutics

You are here

Product Type

Development Stage

Therapeutic Area

Institutes and Centers